BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31400525)

  • 1. Hemorrhage Risk of Untreated Isolated Cerebral Cavernous Malformations.
    Kearns KN; Chen CJ; Yagmurlu K; Capek S; Buell TJ; Taylor DG; Pomeraniec IJ; Park MS; Kalani MY
    World Neurosurg; 2019 Nov; 131():e557-e561. PubMed ID: 31400525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zabramski classification in predicting the occurrence of symptomatic intracerebral hemorrhage in sporadic cerebral cavernous malformations.
    Wang J; Yu QF; Huo R; Sun YF; Jiao YM; Xu HY; Zhang JZ; Zhao SZ; He QH; Wang S; Zhao JZ; Cao Y
    J Neurosurg; 2024 Mar; 140(3):792-799. PubMed ID: 37724811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations.
    Schneble HM; Soumare A; Hervé D; Bresson D; Guichard JP; Riant F; Tournier-Lasserve E; Tzourio C; Chabriat H; Stapf C
    Stroke; 2012 Dec; 43(12):3196-9. PubMed ID: 23150651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solitary Sporadic Cerebral Cavernous Malformations: Risk Factors of First or Recurrent Symptomatic Hemorrhage and Associated Functional Impairment.
    Dammann P; Jabbarli R; Wittek P; Oppong MD; Kneist A; Zhu Y; Wrede K; Müller O; Forsting M; Sure U
    World Neurosurg; 2016 Jul; 91():73-80. PubMed ID: 27058610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
    Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
    J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic Hemorrhage From Cerebral Cavernous Malformations: Evidence from a Cohort Study.
    Gomez-Paz S; Maragkos GA; Salem MM; Ascanio LC; Lee M; Enriquez-Marulanda A; Orrego-Gonzalez E; Kicielinski K; Moore JM; Ogilvy CS; Thomas AJ
    World Neurosurg; 2020 Mar; 135():e477-e487. PubMed ID: 31843731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for symptomatic solitary cerebral cavernous malformations considered high risk for resection.
    Lunsford LD; Khan AA; Niranjan A; Kano H; Flickinger JC; Kondziolka D
    J Neurosurg; 2010 Jul; 113(1):23-9. PubMed ID: 20170299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of thrombolysis in patients with acute ischemic stroke and cerebral cavernous malformations.
    Erdur H; Scheitz JF; Tütüncü S; Fiebach JB; Endres M; Werring DJ; Nolte CH
    Stroke; 2014 Jun; 45(6):1846-8. PubMed ID: 24788970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history and imaging prevalence of cavernous malformations in children and young adults.
    Al-Holou WN; O'Lynnger TM; Pandey AS; Gemmete JJ; Thompson BG; Muraszko KM; Garton HJ; Maher CO
    J Neurosurg Pediatr; 2012 Feb; 9(2):198-205. PubMed ID: 22295927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female Hormone Therapy and Risk of Intracranial Hemorrhage From Cerebral Cavernous Malformations: A Multicenter Observational Cohort Study.
    Zuurbier SM; Santos AN; Flemming KD; Schmidt B; Jabbarli R; Lanzino G; Sure U; Dammann P
    Neurology; 2023 Apr; 100(16):e1673-e1679. PubMed ID: 36754635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma Knife radiosurgery for cerebral cavernous malformation.
    Lee CC; Wang WH; Yang HC; Lin CJ; Wu HM; Lin YY; Hu YS; Chen CJ; Chen YW; Chou CC; Liu YT; Chung WY; Shiau CY; Guo WY; Hung-Chi Pan D; Hsu SPC
    Sci Rep; 2019 Dec; 9(1):19743. PubMed ID: 31874979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Murine Models of Cerebral Cavernous Malformations.
    Detter MR; Shenkar R; Benavides CR; Neilson CA; Moore T; Lightle R; Hobson N; Shen L; Cao Y; Girard R; Zhang D; Griffin E; Gallione CJ; Awad IA; Marchuk DA
    Angiogenesis; 2020 Nov; 23(4):651-666. PubMed ID: 32710309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of cerebral cavernous malformations.
    Ene C; Kaul A; Kim L
    Handb Clin Neurol; 2017; 143():227-232. PubMed ID: 28552144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of familial and sporadic pediatric cerebral cavernous malformations and outcomes.
    Jaman E; Abdallah HM; Zhang X; Greene S
    J Neurosurg Pediatr; 2023 Oct; 32(4):506-513. PubMed ID: 37503918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic medication and bleeding risk in patients with cerebral cavernous malformations: a cohort study.
    Bervini D; Jaeggi C; Mordasini P; Schucht P; Raabe A
    J Neurosurg; 2018 Jun; 130(6):1922-1930. PubMed ID: 29882707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.
    Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H;
    J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging.
    Flemming KD; Graff-Radford J; Aakre J; Kantarci K; Lanzino G; Brown RD; Mielke MM; Roberts RO; Kremers W; Knopman DS; Petersen RC; Jack CR
    JAMA Neurol; 2017 Jul; 74(7):801-805. PubMed ID: 28492932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding Risk of Cerebral Cavernous Malformations in Patients on Statin and Antiplatelet Medication: A Cohort Study.
    Marques LL; Jaeggi C; Branca M; Raabe A; Bervini D; Goldberg J
    Neurosurgery; 2023 Sep; 93(3):699-705. PubMed ID: 36999926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of future haemorrhage from cerebral cavernous malformations: a retrospective cohort study.
    Gillespie CS; Alnaham KE; Richardson GE; Mustafa MA; Taweel BA; Islim AI; Hannan CJ; Chavredakis E
    Neurosurg Rev; 2023 Feb; 46(1):52. PubMed ID: 36763222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.
    Horne MA; Flemming KD; Su IC; Stapf C; Jeon JP; Li D; Maxwell SS; White P; Christianson TJ; Agid R; Cho WS; Oh CW; Wu Z; Zhang JT; Kim JE; Ter Brugge K; Willinsky R; Brown RD; Murray GD; Al-Shahi Salman R;
    Lancet Neurol; 2016 Feb; 15(2):166-173. PubMed ID: 26654287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.